Selim Cellek

Years Active: 2014-2022
Publications (10 Years): 4

Anglia Ruskin University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Anglia Ruskin University

United Kingdom

Interim Deputy Dean (Research and Innovation) :: Faculty of Health, Education, Medicine and Social Care

Anglia Ruskin University

United Kingdom

Director :: Medical technology Research Centre

Publications

Marcus M Ilg, Alice R Lapthorn, David J Ralph, Selim Cellek
Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease. PloS one 17 (12) (2022)
Marcus M Ilg, Alice R Lapthorn, David J Ralph, Selim Cellek
Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease. PloS one 17 (12) (2022)
Marcus M Ilg, Alice R Lapthorn, David J Ralph, Selim Cellek
Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease. PloS one 17 (12) (2022)
Marcus M Ilg, Alice R Lapthorn, David J Ralph, Selim Cellek
Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease. PloS one 17 (12) (2022)
Carla Loreto, Giampiero La Rocca, Rita Anzalone, Rosario Caltabiano, Giuseppe Vespasiani, Sergio Castorina, David J Ralph, Selim Cellek, Giuseppe Musumeci, Salvatore Giunta, Rados Djinovic, Dragoslav Basic, Salvatore Sansalone
The role of intrinsic pathway in apoptosis activation and progression in Peyronie's disease. BioMed research international 2014 (2014)

Selim Cellek.css-eqlu8i{font-size:small;padding-left:4px;}